A Phase 1b Study Evaluating the Safety and Pharmacokinetics of Venetoclax as a Single-Agent and in Combination with Azacitidine in Subjects with Relapsed/Refractory Myelodysplastic Syndromes
NOT ENROLLING
Trial ID:
NCT02966782 Protocol # :
17-187
Phase
I
Disease Sites
Other Hematopoietic
Principal Investigator
Garcia, Jacqueline, S
Site Investigator
Brunner, Andrew
Site Research Nurses
Ramos, Aura
Som, Tina
Toomey-Mathews, Ellen
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #17-187
17-187